Parathyroid hyperplasia is the enlargement of all four parathyroid glands. The parathyroid glands are four glands in the neck that produce parathyroid hormone (PTH).
Causes, incidence, and risk factors:
Parathyroid hyperplasia may occur sporadically (in persons without a family history of the disease) or as part of three inherited syndromes: multiple endocrine neoplasia 1 (MEN1) , MEN 2A , and isolated familial hyperparathyroidism .
In the familial syndromes, a mutated gene is passed down in an autosomal dominant fashion. That means you only need to get the gene from one parent to develop the condition.
In MEN 1, the problems in the parathyroids are associated with other tumors in the pituitary and the pancreas. In MEN 2A, the overactivity of the parathyroids is associated with tumors in the adrenal gland or thyroid. See the specific articles for more information on the causes of these syndromes.
Symptoms may include:
Surgery is the preferred treatment. Usually 3 and 1/2 glands are removed. The remaining tissue may be implanted in the forearm so a doctor can easily operate on it if symptoms come back. This tissue will also help the body control calcium levels.
Increased calcium levels persist or return about 20% of the time after surgery.
Parathyroid hyperplasia causes about 15% of cases of hyperparathyroidism, which leads to an increase in blood calcium levels.
Complications include increased calcium in the kidneys and osteitis fibrosa cystica .
Patients may also have complications from the other endocrine tumors that are part of the multiple endocrine neoplasia syndromes. See:MEN 1 andMEN 2A
Calling your health care provider:
Call your health care provider if you have any symptoms of hypercalcemia, or there is a family history of any of the MEN syndromes
Patients with a family history of the MEN may have genetic screening to check for the defective gene. Those who have the defective gene may have routine screening tests to detect any early symptoms.
Wysolmerski JJ. Insogna KL. The Parathyroid Glands, Hypercalcemia, and Hypocalcemia. In: Kronenberg HM, Schlomo M, Polansky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 11th ed. St. Louis, Mo: WB Saunders; 2008: chap. 266.
Bringhurst FR, Demay MB, Kronenberg HM. Disorders of Mineral Metabolism. In: Kronenberg HM, Schlomo M, Polansky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 11th ed. St. Louis, Mo: WB Saunders; 2008: chap. 27.
|Review Date: 8/31/2010|
Reviewed By: Ari S. Eckman, MD, Chief, Division of Endocrinology, Diabetes and Metabolism, Trinitas Regional Medical Center, Elizabeth, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.